Development of an epigenetic age predictor for costal cartilage with a simultaneous somatic tissue differentiation system.


Journal

Forensic science international. Genetics
ISSN: 1878-0326
Titre abrégé: Forensic Sci Int Genet
Pays: Netherlands
ID NLM: 101317016

Informations de publication

Date de publication:
11 2023
Historique:
received: 14 04 2023
revised: 13 09 2023
accepted: 27 09 2023
medline: 30 10 2023
pubmed: 2 10 2023
entrez: 2 10 2023
Statut: ppublish

Résumé

Age prediction from DNA has been a topic of interest in recent years due to the promising results obtained when using epigenetic markers. Since DNA methylation gradually changes across the individual's lifetime, prediction models have been developed accordingly for age estimation. The tissue-dependence for this biomarker usually necessitates the development of tissue-specific age prediction models, in this way, multiple models for age inference have been constructed for the most commonly encountered forensic tissues (blood, oral mucosa, semen). The analysis of skeletal remains has also been attempted and prediction models for bone have now been reported. Recently, the VISAGE Enhanced Tool was developed for the simultaneous DNA methylation analysis of 8 age-correlated loci using targeted high-throughput sequencing. It has been shown that this method is compatible with epigenetic age estimation models for blood, buccal cells, and bone. Since when dealing with decomposed cadavers or postmortem samples, cartilage samples are also an important biological source, an age prediction model for cartilage has been generated in the present study based on methylation data collected using the VISAGE Enhanced Tool. In this way, we have developed a forensic cartilage age prediction model using a training set composed of 109 samples (19-74 age range) based on DNA methylation levels from three CpGs in FHL2, TRIM59 and KLF14, using multivariate quantile regression which provides a mean absolute error (MAE) of ± 4.41 years. An independent testing set composed of 72 samples (19-75 age range) was also analyzed and provided an MAE of ± 4.26 years. In addition, we demonstrate that the 8 VISAGE markers, comprising EDARADD, TRIM59, ELOVL2, MIR29B2CHG, PDE4C, ASPA, FHL2 and KLF14, can be used as tissue prediction markers which provide reliable blood, buccal cells, bone, and cartilage differentiation using a developed multinomial logistic regression model. A training set composed of 392 samples (n = 87 blood, n = 86 buccal cells, n = 110 bone and n = 109 cartilage) was used for building the model (correct classifications: 98.72%, sensitivity: 0.988, specificity: 0.996) and validation was performed using a testing set composed of 192 samples (n = 38 blood, n = 36 buccal cells, n = 46 bone and n = 72 cartilage) showing similar predictive success to the training set (correct classifications: 97.4%, sensitivity: 0.968, specificity: 0.991). By developing both a new cartilage age model and a tissue differentiation model, our study significantly expands the use of the VISAGE Enhanced Tool while increasing the amount of DNA methylation-based information obtained from a single sample and a single forensic laboratory analysis. Both models have been placed in the open-access Snipper forensic classification website.

Identifiants

pubmed: 37783021
pii: S1872-4973(23)00111-4
doi: 10.1016/j.fsigen.2023.102936
pii:
doi:

Substances chimiques

Genetic Markers 0
TRIM59 protein, human 0
Tripartite Motif Proteins 0
Intracellular Signaling Peptides and Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

102936

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors have declared no conflict of interest.

Auteurs

A Freire-Aradas (A)

Forensic Genetics Unit, Institute of Forensic Sciences, University of Santiago de Compostela, Spain. Electronic address: ana.freire@usc.es.

M Tomsia (M)

Department of Forensic Medicine and Forensic Toxicology, Medical University of Silesia, Katowice, Poland.

D Piniewska-Róg (D)

Department of Forensic Medicine, Jagiellonian University Medical College, Kraków, Poland.

A Ambroa-Conde (A)

Forensic Genetics Unit, Institute of Forensic Sciences, University of Santiago de Compostela, Spain.

M A Casares de Cal (MA)

CITMAga (Center for Mathematical Research and Technology of Galicia), University of Santiago de Compostela, Spain.

A Pisarek (A)

Institute of Zoology and Biomedical Research, Jagiellonian University, Kraków, Poland.

A Gómez-Tato (A)

CITMAga (Center for Mathematical Research and Technology of Galicia), University of Santiago de Compostela, Spain.

J Álvarez-Dios (J)

Faculty of Mathematics, University of Santiago de Compostela, Spain.

E Pośpiech (E)

Malopolska Centre of Biotechnology, Jagiellonian University, Kraków, Poland; Department of Forensic Genetics, Pomeranian Medical University in Szczecin, Poland.

W Parson (W)

Institute of Legal Medicine, Medical University of Innsbruck, Austria; Forensic Science Program, Pennsylvania State University, PA, USA.

M Kayser (M)

Department of Forensic Molecular Biology, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands.

C Phillips (C)

Forensic Genetics Unit, Institute of Forensic Sciences, University of Santiago de Compostela, Spain.

W Branicki (W)

Institute of Zoology and Biomedical Research, Jagiellonian University, Kraków, Poland; Institute of Forensic Research, Kraków, Poland. Electronic address: wojciech.branicki@uj.edu.pl.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH